IDH1 and central nervous system cancer: In spite of the limited number of cases with combined IDH1 mutation and 11p deletion, it would be interesting to explore this finding in larger cohorts given the importance of IDH1 mutations in some of the emerging subtype classification systems developed for glioma (40,46–49).